Abstract
Virus-like particles (VLPs) are a promising and developing option for vaccination and gene therapy. They are also interesting as shuttles for drug targeting. Currently, several different gene expression systems are available, among which the silkworm expression system is known for its mass production capacity. However, cost-effective purification with high purity of the target protein is a particular bottleneck for this system. The present review evaluates the advances in the purification of VLPs, especially from silkworm larval hemolymph. Beginning with applicable pre-treatments for VLPs over to chromatography methods and quality control of the purified VLPs. Whereupon the main focus is on the different chromatography approaches for the purification, but the structure of the VLPs and their intended use for humans make also the quality control important. Within this, the stability of the VLPs which has to be considered for the purification is as well discussed.
Similar content being viewed by others
References
Catrice EVB, Sainsbury F (2015) Assembly and purification of polyomavirus-like particles from plants. Mol Biotechnol 57:904–913
Deo VK, Tsuji Y, Yasuda T, Kato T, Sakamoto N, Suzuki H, Park EY (2011) Expression of an RSV-gag virus-like particle in insect cell lines and silkworm larvae. J Virol Methods 177:147–152
Deo VK, Yoshimatsu K, Otsuki T, Dong J, Kato T, Park EY (2013) Display of Neospora caninum surface protein related sequence 2 on Rous sarcoma virus-derived gag protein virus-like particles. J Biotechnol 165:69–75
Deo VK, Kato T, Park EY (2015) Chimeric virus-like particles made using GAG and M1 capsid proteins providing dual drug delivery and vaccination platform. Mol Pharm 12:839–845
Deo VK, Kato T, Park EY (2016) Virus-like particles displaying recombinant short-chain fragment region and interleukin 2 for targeting colon cancer tumors and attracting macrophages. J Pharm Sci 105:1614–1622
Dong J, Harada M, Yoshida S, Kato Y, Murakawa A, Ogata M, Kato T, Usui T, Park EY (2013) Expression and purification of bioactive hemagglutinin protein of highly pathogenic avian influenza A (H5N1) in silkworm larvae. J Virol Methods 194:271–276
Du P, Sun S, Dong J, Zhi X, Chang Y, Teng Z, Guo H, Liu Z (2017) Purification of foot-and-mouth disease virus by heparin as ligand for certain strains. J Chromatogr B Analyt Technol Biomed Life Sci 1049–1050:16–23
Galaway FA, Stockley PG (2013) MS2 viruslike particles: a robust, semisynthetic targeted drug delivery platform. Mol Pharm 10:59–68
Geng X, Doitsh G, Yang Z, Galloway NLK, Greene WC (2014) Efficient delivery of lentiviral vectors into resting human CD4 T cells. Gene Ther 21:444–449
Hahne T, Palaniyandi M, Kato T, Fleischmann P, Wätzig H, Park EY (2014) Characterization of human papillomavirus 6b L1 virus-like particles isolated from silkworms using capillary zone electrophoresis. J Biosci Bioeng 118:311–314
Hu L, Trefethen JM, Zeng Y, Yee L et al (2011) Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles. J Pharm Sci 100:5156–5173
Kato T, Kajikawa M, Maenaka K, Park EY (2010) Silkworm expression system as a platform technology in life science. Appl Microbiol Biotechnol 85:459–470
Kato T, Yui M, Deo VK, Park EY (2015) Development of rous sarcoma virus-like particles displaying hcc49 scfv for specific targeted drug delivery to human colon carcinoma cells. Pharm Res 32:3699–3707
Krammer F, Schinko T, Palmberger D, Tauer C, Messner P, Grabherr R (2010) Trichoplusia ni cells (high five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol 45:226–234
Kröber T, Knöchlein A, Eisold K, Kalbfuß-Zimmermann B, Reichl U (2010) DNA depletion by precipitation in the purification of cell culture-derived influenza vaccines. Chem Eng Technol 33:941–959
Kumar M, Saravanan P, Jalali SK (2016) Expression and purification of virus like particles (VLPs) of foot-and-mouth disease virus in Eri silkworm (Samia cynthia ricini) larvae. Virusdisease 27:84–90
Kurosawa Y, Saito M, Kobayashi S, Okuyama T (2012) Purification of dengue virus particles by one-step ceramic hydroxyapatite chromatography. WJV 02:155–160
Lee MFX, Chan ES, Tey BT (2014) Negative chromatography: progress, applications and future perspectives. Process Biochem 49:1005–1011
Lee MFX, Chan ES, Tan WS, Tam KC, Tey BT (2015) Negative chromatography purification of hepatitis B virus-like particles using poly(oligo(ethylene glycol) methacrylate) grafted cationic adsorbent. J Chromatogr A 1415:161–165
Lee MFX, Chan ES, Tan WS, Tam KC, Tey BT (2016) Negative chromatography of hepatitis B virus-like particle: comparative study of different adsorbent designs. J Chromatogr A 1445:1–9
Leuchs B, Frehtman V, Riese M, Muller M, Rommelaere J (2017) A novel scalable, robust downstream process for oncolytic rat parvovirus: isoelectric point-based elimination of empty particles. Appl Microbiol Biotechnol 101:3143–3152
Lin S-Y, Chiu H-Y, Chiang B-L, Hu Y-C (2015) Development of EV71 virus-like particle purification processes. Vaccine 33:5966–5973
Lua LHL, Connors NK, Sainsbury F, Chuan YP, Wibowo N, Middelberg APJ (2014) Bioengineering virus-like particles as vaccines. Biotechnol Bioeng 111:425–440
Marichal-Gallardo P, Pieler MM, Wolff MW, Reichl U (2017) Steric exclusion chromatography for purification of cell culture-derived influenza a virus using regenerated cellulose membranes and polyethylene glycol. J Chromatogr A 1483:110–119
Mitsudome T, Xu J, Nagata Y, Masuda A, Iiyama K, Morokuma D, Li Z, Mon H, Lee JM, Kusakabe T (2014) Expression, purification, and characterization of endo-beta-N-acetylglucosaminidase H using baculovirus-mediated silkworm protein expression system. Appl Biochem Biotechnol 172:3978–3988
Molinari P, Peralta A, Taboga O (2008) Production of rotavirus-like particles in Spodoptera frugiperda larvae. J Virol Methods 147:364–367
Morokuma D, Xu J, Hino M, Mon H, Merzaban JS, Takahashi M, Kusakabe T, Lee JM (2017) Expression and characterization of human beta-1, 4-galactosyltransferase 1 (beta4GalT1) using silkworm-baculovirus expression system. Mol Biotechnol 59:151–158
Mundle ST, Kishko M, Groppo R, DiNapoli J, Hamberger J, McNeil B, Kleanthous H, Parrington M, Zhang L, Anderson SF (2016) Core bead chromatography for preparation of highly pure, infectious respiratory syncytial virus in the negative purification mode. Vaccine 34:3690–3696
Nerome K, Matsuda S, Maegawa K, Sugita S, Kuroda K, Kawasaki K, Nerome R (2017) Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: a possible oral vaccine. Vaccine 35:738–746
Nestola P, Peixoto C, Silva RRJS, Alves PM, Mota JPB, Carrondo MJT (2015) Improved virus purification processes for vaccines and gene therapy. Biotechnol Bioeng 112:843–857
Palaniyandi M, Kato T, Park EY (2012) Expression of human papillomavirus 6b L1 protein in silkworm larvae and enhanced green fluorescent protein displaying on its virus-like particles. Springerplus 1:29
Steppert P, Burgstaller D, Klausberger M, Berger E et al (2016) Purification of HIV-1 gag virus-like particles and separation of other extracellular particles. J Chromatogr A 1455:93–101
Steppert P, Burgstaller D, Klausberger M, Kramberger P, Tover A, Berger E, Nobauer K, Razzazi-Fazeli E, Jungbauer A (2017) Separation of HIV-1 gag virus-like particles from vesicular particles impurities by hydroxyl-functionalized monoliths. J Sep Sci 40:979–990
Strods A, Ose V, Bogans J, Cielens I, Kalnins G, Radovica I, Kazaks A, Pumpens P, Renhofa R (2015) Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications. Sci Rep 5:11639
Sviben D, Forcic D, Ivancic-Jelecki J, Halassy B, Brgles M (2017) Recovery of infective virus particles in ion-exchange and hydrophobic interaction monolith chromatography is influenced by particle charge and total-to-infective particle ratio. J Chromatogr B Analyt Technol Biomed Life Sci 1054:10–19
Xue L, Liu J, Wang Q, Zhang C, Xu L, Luo J, Wang J, Qin C, Liu Y, Su Z (2017) Purification and assembling a fused capsid protein as an enterovirus 71 vaccine candidate from inclusion bodies to pentamer-based nanoparticles. Biochem Eng J 117:139–146
Yao L, Wang S, Su S, Yao N, He J, Peng L, Sun J (2012) Construction of a baculovirus-silkworm multigene expression system and its application on producing virus-like particles. PLoS ONE 7:e32510
Zeltins A (2013) Construction and characterization of virus-like particles: a review. Mol Biotechnol 53:92–107
Zhao Q, Modis Y, High K, Towne V et al (2012) Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Virol J 9:52
Acknowledgements
The authors wish to thank Dr. Tatsuya Kato of Research Institute of Green Science and Technology in Shizuoka University for critical reading of the manuscript.
Supporting Information
Supplementary Table S1—Some purifications from proteins from the silkworm or purifications from viruses and virus-like particles (VLPs) from other expression systems.
Supplementary Fig. S1—The heparin affinity purification.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Minkner, R., Park, E.Y. Purification of virus-like particles (VLPs) expressed in the silkworm Bombyx mori. Biotechnol Lett 40, 659–666 (2018). https://doi.org/10.1007/s10529-018-2516-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-018-2516-5